Either the stakeholders issuing the warnings overstated the risk of widespread closings—or COVID-era emergency funds succeeded in heading off a calamity of national proportions. Either way, patient access has taken a hit here and there.
A special report is raising new concerns about a hospital’s lackluster response to a radiologist's concerns of abuse happening in the organization's NICU.
Major TAVR policy changes appear to be on the way—should clinicians be excited or concerned? Leading U.S. medical societies are sharing their early reactions.
Midwest Radiology Director of Recruiting Laurent Grignon, MD, recently spoke with Radiology Business about the successes, divulging some of his strategies.
As the Medicare drug price negotiation program enters its fourth year next year, regulators are looking to put a set of guidelines in place that make it clear how medications are selected for inclusion and what the deliberation process will look like for biopharma companies.
Coming in at just 0.04 mmol gadolinium per kilogram body weight, gadoquatrane has 60% less gadolinium than the lowest dose GBCA currently on the market.
This recall was put in place due to a risk of the included adhesive not working. Nothing needs to be returned, but clinicians should not use the adhesive that comes inside the procedure kits.
Either the stakeholders issuing the warnings overstated the risk of widespread closings—or COVID-era emergency funds succeeded in heading off a calamity of national proportions. Either way, patient access has taken a hit here and there.
